Commentary

The article reports on the results of a study showing that cholinesterase inhibitors provide little benefits for informal carers of community dwelling people with Alzheimer's disease. Cholinesterase inhibitors increase synaptic levels of acetylcholine and produce modest improvements in symptoms in clinical trials.